CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 122 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2023. The put-call ratio across all filers is 1.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,661 | -76.6% | 580 | -65.9% | 0.00% | – |
| Q2 2023 | $54,043 | +154308.6% | 1,700 | +19.7% | 0.00% | – |
| Q1 2023 | $35 | -22.2% | 1,420 | 0.0% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 1,420 | 0.0% | 0.00% | – |
| Q3 2022 | $40,000 | +11.1% | 1,420 | +2.9% | 0.00% | – |
| Q2 2022 | $36,000 | +9.1% | 1,380 | +46.8% | 0.00% | – |
| Q1 2022 | $33,000 | -42.1% | 940 | -57.2% | 0.00% | – |
| Q4 2021 | $57,000 | – | 2,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
| Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
| Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
| Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
| Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
| Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
| Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
| Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
| HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
| FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |